The banks have also stated that the newly formed company will have ten banks and financial institutions as its shareholders. They have not named other shareholders of the proposed company.
Biocon shares rise 2% on 10-year Pertuzumab supply deal for breast cancer therapy in Brazil
Biocon shares rose after the company secured a 10-year Pertuzumab supply contract in Brazil. The consortium with Bahiafarma and Bionovis received full allocation under the